Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Sept 2026 for DEXCOM INC, €476k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Augustinos Nicholas: trading record in brief
Augustinos Nicholas discloses dealings in Dexcom Inc to SEC (Form 4). Over a trading history stretching from 14 September 2026 to 15 September 2026, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 15 September 2026: a transaction of €476k, in Dexcom Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Augustinos Nicholas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
6,539 shares@ US$84.04Common StockSEC144:0001959173-26-006959
1,550 shares@ US$84.020.0004% mcap4.4% of flowCommon StockSEC144:0001959173-26-006910
2 of 2 declarations
